(-)-Arctigenin multiple interactions ISO RGD:1313354 6480464 [Quercetin co-treated with arctigenin] results in increased expression of NKX3-1 protein CTD PMID:25380086 (-)-Arctigenin increases expression ISO RGD:1313354 6480464 arctigenin results in increased expression of NKX3-1 protein CTD PMID:25380086 17beta-estradiol multiple interactions ISO RGD:1313354 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of NKX3-1 mRNA] more ... CTD PMID:17131305 , PMID:30165855 17beta-estradiol increases expression ISO RGD:1313354 6480464 Estradiol results in increased expression of NKX3-1 mRNA CTD PMID:17131305 , PMID:31614463 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:1313354 6480464 bicalutamide inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA] more ... CTD PMID:11751618 more ... 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:1313354 6480464 Metribolone results in increased expression of NKX3-1 mRNA, Metribolone results in increased expression of NKX3-1 protein CTD PMID:11751618 more ... 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one decreases expression ISO RGD:1313354 6480464 Metribolone results in decreased expression of NKX3-1 mRNA CTD PMID:12711008 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:1313354 6480464 Dihydrotestosterone results in decreased expression of NKX3-1 mRNA CTD PMID:12711008 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:1313354 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dihydrotestosterone results in increased expression of NKX3-1 mRNA] CTD PMID:17131305 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1313354 6480464 Dihydrotestosterone results in increased expression of NKX3-1 mRNA CTD PMID:17131305 , PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313355 6480464 Tetrachlorodibenzodioxin affects the expression of NKX3-1 mRNA CTD PMID:24058054 2,4-Dihydroxybenzophenone decreases expression ISO RGD:1313354 6480464 2, 4-dihydroxybenzophenone analog results in decreased expression of NKX3-1 mRNA CTD PMID:33684284 4,4'-sulfonyldiphenol increases expression ISO RGD:1313355 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NKX3-1 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine increases expression ISO RGD:1313354 6480464 Decitabine results in increased expression of NKX3-1 mRNA CTD PMID:18174752 9-cis-retinoic acid increases expression ISO RGD:1313354 6480464 Alitretinoin results in increased expression of NKX3-1 mRNA, Alitretinoin results in increased expression of NKX3-1 protein CTD PMID:16763719 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of NKX3-1 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1313354 6480464 Aflatoxin B1 results in increased expression of NKX3-1 mRNA CTD PMID:22100608 all-trans-retinoic acid increases expression ISO RGD:1313354 6480464 Tretinoin results in increased expression of NKX3-1 mRNA, Tretinoin results in increased expression of NKX3-1 protein CTD PMID:16817226 all-trans-retinoic acid affects expression ISO RGD:1313354 6480464 Tretinoin affects the expression of NKX3-1 mRNA CTD PMID:31600526 antirheumatic drug decreases expression ISO RGD:1313354 6480464 Antirheumatic Agents results in decreased expression of NKX3-1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1313354 6480464 aristolochic acid I results in increased expression of NKX3-1 mRNA CTD PMID:33212167 benzo[a]pyrene affects methylation ISO RGD:1313354 6480464 Benzo(a)pyrene affects the methylation of NKX3-1 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1313354 6480464 7 more ... CTD PMID:19150397 bicalutamide decreases expression ISO RGD:1313354 6480464 bicalutamide results in decreased expression of NKX3-1 mRNA CTD PMID:15638997 , PMID:28500234 bicalutamide multiple interactions ISO RGD:1313354 6480464 [Niclosamide co-treated with bicalutamide] results in decreased expression of NKX3-1 mRNA more ... CTD PMID:11751618 more ... bisphenol A increases expression ISO RGD:1313354 6480464 bisphenol A results in increased expression of NKX3-1 mRNA CTD PMID:23146750 bisphenol A increases expression ISO RGD:1313355 6480464 bisphenol A results in increased expression of NKX3-1 mRNA CTD PMID:30951980 bisphenol A affects methylation ISO RGD:1313355 6480464 bisphenol A affects the methylation of NKX3-1 promoter CTD PMID:27334623 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NKX3-1 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:1313355 6480464 bisphenol F results in increased expression of NKX3-1 mRNA CTD PMID:30951980 butanal increases expression ISO RGD:1313354 6480464 butyraldehyde results in increased expression of NKX3-1 mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of NKX3-1 mRNA CTD PMID:19167457 cadmium dichloride increases expression ISO RGD:1313354 6480464 Cadmium Chloride results in increased expression of NKX3-1 mRNA CTD PMID:11751618 cadmium dichloride multiple interactions ISO RGD:1313354 6480464 bicalutamide inhibits the reaction [Cadmium Chloride results in increased expression of NKX3-1 mRNA] CTD PMID:11751618 celastrol decreases expression ISO RGD:1313354 6480464 celastrol results in decreased expression of NKX3-1 mRNA CTD PMID:17010675 chlordecone decreases expression ISO RGD:1313355 6480464 Chlordecone results in decreased expression of NKX3-1 mRNA CTD PMID:33711761 cisplatin increases expression ISO RGD:1313354 6480464 Cisplatin results in increased expression of NKX3-1 mRNA CTD PMID:19561079 clofibrate increases expression ISO RGD:1313355 6480464 Clofibrate results in increased expression of NKX3-1 mRNA CTD PMID:17585979 copper atom multiple interactions ISO RGD:1313354 6480464 [Chelating Agents binds to Copper] which results in increased expression of NKX3-1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1313354 6480464 [Chelating Agents binds to Copper] which results in increased expression of NKX3-1 mRNA CTD PMID:30911355 crocidolite asbestos affects expression ISO RGD:1313354 6480464 Asbestos, Crocidolite affects the expression of NKX3-1 mRNA CTD PMID:24160326 crocidolite asbestos increases expression ISO RGD:1313354 6480464 Asbestos, Crocidolite results in increased expression of NKX3-1 mRNA CTD PMID:18687144 , PMID:25757056 crocidolite asbestos decreases expression ISO RGD:1313354 6480464 Asbestos, Crocidolite results in decreased expression of NKX3-1 mRNA CTD PMID:25351596 curcumin decreases expression ISO RGD:1313354 6480464 Curcumin results in decreased expression of NKX3-1 mRNA, Curcumin results in decreased expression of NKX3-1 protein CTD PMID:17303007 , PMID:18719366 daidzein decreases expression ISO RGD:1313354 6480464 daidzein results in decreased expression of NKX3-1 mRNA CTD PMID:16865672 dapsone multiple interactions ISO RGD:1313354 6480464 Dapsone analog inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA] CTD PMID:21440447 difenoconazole decreases expression ISO RGD:1313354 6480464 difenoconazole results in decreased expression of NKX3-1 mRNA CTD PMID:12711008 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:1313354 6480464 bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA] CTD PMID:29462692 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression ISO RGD:1313354 6480464 Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA, Antimony Potassium Tartrate results in increased expression of NKX3-1 protein CTD PMID:29462692 doxorubicin decreases expression ISO RGD:1313354 6480464 Doxorubicin results in decreased expression of NKX3-1 mRNA CTD PMID:29803840 enzalutamide decreases expression ISO RGD:1313354 6480464 enzalutamide results in decreased expression of NKX3-1 mRNA CTD PMID:29581250 , PMID:32184358 enzalutamide multiple interactions ISO RGD:1313354 6480464 enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of NKX3-1 mRNA], NVP-BHG712 promotes the reaction [enzalutamide results in decreased expression of NKX3-1 mRNA] CTD PMID:32184358 equol decreases expression ISO RGD:1313354 6480464 Equol results in decreased expression of NKX3-1 mRNA CTD PMID:16865672 fentin acetate decreases expression ISO RGD:1313354 6480464 phentin acetate results in decreased expression of NKX3-1 mRNA CTD PMID:12711008 flufenamic acid multiple interactions ISO RGD:1313354 6480464 Flufenamic Acid inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA] CTD PMID:10537180 flutamide multiple interactions ISO RGD:1313354 6480464 [Flutamide binds to and results in decreased activity of AR protein] which results in decreased expression of NKX3-1 protein CTD PMID:17303007 flutamide decreases expression ISO RGD:1313354 6480464 Flutamide results in decreased expression of NKX3-1 protein CTD PMID:17303007 fulvestrant multiple interactions ISO RGD:1313354 6480464 fulvestrant inhibits the reaction [Estradiol results in increased expression of NKX3-1 mRNA] CTD PMID:17131305 fulvestrant multiple interactions ISO RGD:1313355 6480464 fulvestrant inhibits the reaction [Genistein results in decreased expression of NKX3-1 mRNA] CTD PMID:21810550 gedunin decreases expression ISO RGD:1313354 6480464 gedunin results in decreased expression of NKX3-1 mRNA CTD PMID:17010675 genistein decreases expression ISO RGD:1313354 6480464 Genistein results in decreased expression of NKX3-1 mRNA CTD PMID:15378649 , PMID:16865672 genistein increases expression ISO RGD:1313355 6480464 Genistein results in increased expression of NKX3-1 mRNA CTD PMID:21810550 genistein multiple interactions ISO RGD:1313355 6480464 fulvestrant inhibits the reaction [Genistein results in decreased expression of NKX3-1 mRNA] CTD PMID:21810550 indometacin increases expression ISO RGD:1313354 6480464 Indomethacin results in increased expression of NKX3-1 mRNA CTD PMID:16984733 isoflavones decreases expression ISO RGD:1313354 6480464 Isoflavones results in decreased expression of NKX3-1 mRNA CTD PMID:17374662 Licochalcone B increases expression ISO RGD:1313354 6480464 licochalcone B results in increased expression of NKX3-1 mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO RGD:1313354 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NKX3-1 mRNA] CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1313354 6480464 Lipopolysaccharides results in increased expression of NKX3-1 mRNA CTD PMID:35811015 methylisothiazolinone increases expression ISO RGD:1313354 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of NKX3-1 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1313354 6480464 methylmercuric chloride results in increased expression of NKX3-1 mRNA CTD PMID:28001369 methylseleninic acid affects expression ISO RGD:1313354 6480464 methylselenic acid affects the expression of NKX3-1 mRNA CTD PMID:14617803 mibolerone increases expression ISO RGD:1313354 6480464 mibolerone results in increased expression of NKX3-1 mRNA CTD PMID:10537180 mibolerone multiple interactions ISO RGD:1313354 6480464 Flufenamic Acid inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA], Piroxicam inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA] CTD PMID:10537180 niclosamide decreases expression ISO RGD:1313354 6480464 Niclosamide results in decreased expression of NKX3-1 mRNA CTD PMID:28500234 niclosamide multiple interactions ISO RGD:1313354 6480464 [Niclosamide co-treated with bicalutamide] results in decreased expression of NKX3-1 mRNA CTD PMID:28500234 paracetamol increases expression ISO RGD:1313354 6480464 Acetaminophen results in increased expression of NKX3-1 mRNA CTD PMID:21420995 , PMID:29067470 pioglitazone multiple interactions ISO RGD:1313355 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NKX3-1 mRNA CTD PMID:27935865 piroxicam multiple interactions ISO RGD:1313354 6480464 Piroxicam inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA] CTD PMID:10537180 quercetin decreases expression ISO RGD:1313354 6480464 Quercetin results in decreased expression of NKX3-1 mRNA CTD PMID:11238180 quercetin multiple interactions ISO RGD:1313354 6480464 [Quercetin co-treated with arctigenin] results in increased expression of NKX3-1 protein CTD PMID:25380086 quercetin increases expression ISO RGD:1313354 6480464 Quercetin results in increased expression of NKX3-1 protein CTD PMID:25380086 resveratrol decreases expression ISO RGD:1313354 6480464 resveratrol results in decreased expression of NKX3-1 mRNA CTD PMID:18586690 more ... S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1313354 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NKX3-1 mRNA] CTD PMID:35811015 serpentine asbestos affects expression ISO RGD:1313354 6480464 Asbestos, Serpentine affects the expression of NKX3-1 mRNA CTD PMID:24160326 silicon dioxide decreases expression ISO RGD:1313354 6480464 Silicon Dioxide results in decreased expression of NKX3-1 mRNA CTD PMID:25351596 sirtinol decreases expression ISO RGD:1313354 6480464 sirtinol results in decreased expression of NKX3-1 mRNA CTD PMID:22495798 sodium arsenite decreases expression ISO RGD:1313355 6480464 sodium arsenite results in decreased expression of NKX3-1 mRNA CTD PMID:36209798 sodium fluoride decreases expression ISO RGD:1313355 6480464 Sodium Fluoride results in decreased expression of NKX3-1 mRNA CTD PMID:27862939 tert-butyl hydroperoxide increases expression ISO RGD:1313354 6480464 tert-Butylhydroperoxide results in increased expression of NKX3-1 mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:1313355 6480464 1 more ... CTD PMID:33848595 testosterone decreases expression ISO RGD:1313355 6480464 Testosterone deficiency results in decreased expression of NKX3-1 mRNA CTD PMID:33848595 tetramethrin decreases expression ISO RGD:1313354 6480464 tetramethrin results in decreased expression of NKX3-1 mRNA CTD PMID:12711008 triclosan decreases expression ISO RGD:1313354 6480464 Triclosan results in decreased expression of NKX3-1 mRNA CTD PMID:30510588 urethane increases expression ISO RGD:1313354 6480464 Urethane results in increased expression of NKX3-1 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1313355 6480464 Valproic Acid results in increased expression of NKX3-1 mRNA CTD PMID:21427059 valproic acid increases expression ISO RGD:1313354 6480464 Valproic Acid results in increased expression of NKX3-1 mRNA CTD PMID:23179753 more ... vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NKX3-1 mRNA CTD PMID:18220299 XL147 multiple interactions ISO RGD:1313355 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NKX3-1 mRNA CTD PMID:27935865 zinc atom multiple interactions ISO RGD:1313354 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NKX3-1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1313354 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NKX3-1 mRNA CTD PMID:18593933